|
366
|
|
Metastatic central lymph node ratio and predict the malignant potential of FDG-avid lymph nodes in papillary thyroid cancer patients.
|
S. Kwon, J. Kim, S. Kang, S. Jeon, H. Song, H. Bom, J. Min
|
|
365
|
|
Diagnostic performance of C-11 methionine PET using regularized image reconstruction for the prediction of malignant potential in brain tumor
|
S. Kwon, J. Kim, S. Kang, K. Park, H. Sheen, J. Min, H. Song, H. Bom
|
|
364
|
|
Intratumoral metabolic heterogeneity can be useful to select patients for radiotherapy dose-escalation in stage III non-small cell lung cancer
|
S. Kang, H. Kim, K. Park, G. Jeong, H. Park, J. Kim, J. Min
|
|
363
|
|
Clinical implication of preablation thyroglobulin level in differentiated thyroid carcinoma patients underwent recombinant human thyrotropin aided ablative radioiodine treatment
|
H. Park, S. Cho, S. Kang, K. Park, G. Jeong, J. Kim, S. Kwon, J. Min, H. Song, H. Bom
|
|
362
|
|
In vivo imaging of hemoglobin and melanin variations using photoacoustic tomography.
|
H. Kim, V. H. Nguyen, H. Bom, J. Min
|
|
361
|
|
Antibody mimics, fibronectin domain III for EphA2-targeting as a prob in murine tumor model.
|
S. Park, Y. Hong, S. Park, R. H. Kimura, J. Min, S. S. Gambhir
|
|
360
|
|
Molecular Imaging of EGFR-Expressing Tumors with Novel Targeted Protein Scaffold, anti-EGFR Repebody.
|
M. Yun, D. Kim, H. Kim, J. Zheng, A. Pyo, Y. Hong, H. Bom, J. Min
|
|
359
|
|
Both serum thyroglobulin level after I-131 therapy and pattern of I-131 whole body scan should be considered together for the prediction of excellent response in the patients with differentiated thyroid carcinoma.
|
G. Jeong, S. Jeon, H. Park, S. Cho, S. Kang, J. Kim, S. Kwon, J. Min, H. Song, H. Bom
|
|
358
|
|
Both serum thyroglobulin level after I-131 therapy and pattern of I-131 whole body scan should be considered together for the prediction of excellent response in the patients with differentiated thyroid carcinoma.
|
G. Jeong, S. Jeon, H. Park, S. Cho, S. Kang, J. Kim, S. Kwon, J. Min, H. Song, H. Bom
|
|
357
|
|
Synthesis and Evaluation of 65Cu Labeled Repebody for EGFR-mediated Cancer Imaging in Small Animals.
|
A. Pyo, M. Yun, H. Kim, D. Kim, J. Min
|
|
356
|
|
Characterization of focal and diffuse coronary artery disease using coronary flow reserve and fraction flow reserve measured by N-13 ammonia PET and CT coronary angiography.
|
S. Cho, S. Kang, J. Kim, H. Kim, H. Park, J. Cho, S. Kwon, J. Min, H. Song, H. Bom
|
|
355
|
|
[18F]fluorodeoxysorbitol PET Imaging for Visualization of Tumor- Targeting Salmonella typhimurium in Mouse Tumor Models.
|
D. Kim, V. H. Nguyen, H. Kim, A. Pyo, H. Bom, J. Min
|
|
354
|
|
Engineering attenuated salmonella typhimurium to produce heterogenous flagellin B for cancer therapy in host immunity dependent manner
|
Jin Hai Zheng, Seung-Hwan Park, Vu H. Nguyen, Misun Yun, Yeonjin Choo, Hyon E. Choy and Jung-Joon Min
|
|
353
|
|
Targeted imaging with peptides & novel protein scaffolds
|
민정준
|
|
352
|
|
Overview of pathogen-specific molecular imaging
|
민정준
|
